EUVIMEDEUVIMED entdecken
Crossref

HPLC fluorescence assay for measuring the activity of NAPE-PLD and the action of inhibitors affecting this enzyme

Thomas Lange, Tim Depmeier, Timo Strünker, Matthias Lehr

Journal of Pharmaceutical and Biomedical Analysis · 2023

DOI: 10.1016/j.jpba.2023.115354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023. Verfasst von Thomas Lange und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany. Hauptthemen laut MEDLINE: Phospholipase D. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-Acyl phosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD) is the major enzyme for the biosynthesis of the endocannabinoid anandamide. The role of NAPE-PLD in various physiological and pathophysiological conditions is currently under investigation. For example, the enzyme might be involved in the control of neuronal activity, embryonic development and pregnancy, and prostate cancer. We synthesized a novel NAPE-PLD substrate with a fluorogenic pyrene substituent at the N-acyl residue as tool compound for studying this enzyme. As shown by HPLC with fluorescence detection, in rat brain microsomes the substrate was transformed into the expected pyrene-labeled N-acylethanolamine (NAE), but minor amounts of three by-products could also be detected. In the presence of pan-serine hydrolase and secretory phospholipase A2 inhibitors, the generation of these compounds, whose identity was verified using reference substances, was abolished. Based on these results, a method for determining the activity of NAPE-PLD was developed, validated, and applied to evaluate the action of known inhibitors of this enzyme. With human sperm, it was shown that the fluorescent substrate can also be used to study NAPE metabolism in intact cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phospholipase DRatsAnimalsMaleHumansChromatography, High Pressure LiquidSemenEndocannabinoids

Stichwörter der Autor:innen

Fluorescence assayHPLCInhibitorNAPE-PLDPyrene-labeled substrate

Substanzen

Phospholipase DEndocannabinoids

Autor:innen und Institutionen

  • Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.
  • Centre of Reproductive Medicine and Andrology, University Hospital Münster, University of Münster, Domagkstrasse 11, 48149 Münster, Germany.
  • Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany. Electronic address: lehrm@uni-muenster.de.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg

Zitieren

APA

Lange, T., Depmeier, T., Strünker, T., & Lehr, M. (2023). HPLC fluorescence assay for measuring the activity of NAPE-PLD and the action of inhibitors affecting this enzyme. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2023.115354

Vancouver

Lange T, Depmeier T, Strünker T, Lehr M. HPLC fluorescence assay for measuring the activity of NAPE-PLD and the action of inhibitors affecting this enzyme. Journal of Pharmaceutical and Biomedical Analysis. 2023. doi:10.1016/j.jpba.2023.115354

BibTeX
@article{Lange2023,
  author = {Lange, Thomas and Depmeier, Tim and Strünker, Timo and Lehr, Matthias},
  title = {HPLC fluorescence assay for measuring the activity of NAPE-PLD and the action of inhibitors affecting this enzyme},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2023},
  doi = {10.1016/j.jpba.2023.115354}
}
Kostenlos starten →